SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending as its highly active community demonstrates relentless "proof of work" by building a permissionless brand with tangible products like Kendu Spice, soon launching on Amazon. The enthusiastic holders highlight the project's strong real-world presence and continuous development across multiple chains, fueling conviction in its ambitious long-term vision to become a household name.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp (OMER) is trending following the recent FDA approval of YARTEMLEA, its first-in-class treatment for transplant-associated thrombotic microangiopathy, addressing a severe condition with no current alternatives. The community is actively discussing the significant revenue potential from this market monopoly and the company's strengthened financial position due to a major partnership and debt reduction. Investors are keenly awaiting the upcoming conference call for further commercialization details and potential additional catalysts.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as traders navigate expectations of a year-end rally and anticipated Federal Reserve rate cuts, driving significant bullish speculation in the tech-heavy Nasdaq. The recent 2-for-1 stock split has sparked community debate, with many seeing it as a potential catalyst for renewed buying interest, while others express caution regarding amplified market volatility and the long-term sustainability of the AI-driven rally. Sentiment remains divided, balancing aggressive upside bets against concerns over leveraged exposure in a dynamic market.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

ASPC is trending due to extreme price volatility and massive trading volume, fueled by speculation around its low float and high borrow rate. The community is actively debating a potential short squeeze, comparing its wild swings to past parabolic runners, while others warn of a pump and dump scenario, highlighting its nature as a high-risk SPAC play.

Paysafe Ltd. provides online payment solutions. The firm operates through the following segments: Merchant Solutions and Digital Wallet. The Merchant Solutions business segment focuses on card not present and card present solutions for small to medium size business merchants. The Digital Wallet business segment provides wallet based online payment solutions through its Skrill, eCash solutions and NETELLER brands. The company was founded in 1996 and is headquartered in London, the United Kingdom.

Paysafe Limited

Paysafe Ltd

Paysafe Ltd. is trending due to recent weak earnings results and a lowered outlook, fueling a polarized debate among investors. Bears frequently label the company a "SPAC scam" citing continuous underperformance, growing debt, and perceived management incompetence, while a bullish faction contends it is "grossly undervalued" given its payment volumes and strategic initiatives, anticipating a potential re-rate from buybacks or a private takeover. This fintech firm's struggles are contrasted against broader market rallies, amplifying discussions around its long-term viability and ability to deliver consistent growth.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is making significant waves in the cybersecurity landscape, driven by an expanded multi-year partnership with Google Cloud focused on AI security and recent strategic acquisitions. The community is buzzing with discussions on its long-term growth potential in a booming sector, even as some traders evaluate recent price movements as a compelling buy-the-dip opportunity for this platform leader.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is experiencing a surge in trading activity, fueled by broader AI sector momentum and heightened interest in its Gemini-II APU. The community is actively discussing the chip's potential for power-efficient edge AI, especially for defense and drone applications, citing recent government contracts and anticipated multi-modal Large Language Model benchmarks. This positions GSI as a potential disruptor in the expanding market for specialized AI inference hardware.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is at the center of investor discussion as its Anaphylm sublingual film nears a pivotal regulatory decision in January, with many anticipating approval as a convenient, needle-free option for anaphylaxis. The community is actively debating a potential pre-approval rally and short squeeze, highlighting Anaphylm's distinct portability advantage over traditional devices and competitor products. Ongoing FDA workshops on epinephrine access further emphasize the market's evolving landscape and Aquestive's strategic positioning.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1996 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy (LNG) is a focal point as the community discusses its oversold condition and long-term value, driven by escalating global demand for liquefied natural gas. The company is poised to benefit from Europe's hastened pivot away from Russian gas and the immense power requirements of AI data centers, further bolstered by its expanding U.S. export capacity.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending due to significant technical advancements like quantum-safe state proofs and new ecosystem integrations, including regulated payment infrastructure and the Algorand decentralization tracker. This has polarized the community, with many accumulating for its long-term utility and strong fundamentals, while others express frustration over past price performance and concerns regarding the Algorand Foundation's token supply strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BTSG or MEDP: Which Is the Better Value Stock Right Now?

BTSG vs. MEDP: Which Stock Is the Better Value Option?

Medpace Holdings, Inc. $MEDP Shares Sold by Swedbank AB

Swedbank AB lessened its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 18.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities...

Medpace Holdings, Inc. $MEDP Stock Holdings Lessened by Voya Investment Management LLC

Voya Investment Management LLC cut its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 29.5% during the third quarter, according to its most recent disclosure with the...

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.

BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens

BrainsWay stock rises after Optum expands Deep TMS coverage for adolescents, boosting reimbursement visibility.

Medpace Holdings, Inc. $MEDP Shares Acquired by Brighton Jones LLC

Brighton Jones LLC lifted its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 160.4% in the third quarter, according to the company in its most recent filing with the...

Here's Why You Should Retain INSP Stock in Your Portfolio Now

INSP's Inspire V gains traction with strong clinical data, improving reimbursement visibility and cost control, even as inventory and GLP-1 headwinds persist.

Riverbridge Partners LLC Has $187.71 Million Stock Holdings in Medpace Holdings, Inc. $MEDP

Riverbridge Partners LLC lowered its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 15.9% during the 3rd quarter, according to the company in its most recent 13F filing with...

Congress Asset Management Co. Buys 7,190 Shares of Medpace Holdings, Inc. $MEDP

Congress Asset Management Co. lifted its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 12.5% in the third quarter, according to its most recent filing with the SEC. The...

Wall Street Zen Downgrades Medpace (NASDAQ:MEDP) to Hold

Wall Street Zen downgraded shares of Medpace from a "buy" rating to a "hold" rating in a research report on Saturday...

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

MEDP
Medpace Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MEDP News

MEDPMedpace Holdings Inc